Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,772 public trials 697 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

Communication Skills Intervention to Promote Transition Into Survivorship

NCT01483664

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Tampa General Hospital Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Maimonides Medical Center Brooklyn, New York, United States
View Trial Details
Active, Not Recruiting

Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

NCT05222555

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center - USOR Dallas, Texas, United States
  • Vista Oncology Olympia, Washington, United States
  • UK St. Pölten Sankt Pölten, Lower Austria, Austria
View all 62 locations
View Trial Details
Active, Not Recruiting

Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma

NCT01808599

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Créteil Hopital Henri Mondor Créteil, France
  • Dijon CHU Hopital le Bocage Dijon, France
  • Clermont Ferrand CHU Estaing Estaing, France
  • Grenoble CHU Pontchaillou Grenoble, France
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma

NCT05716087

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Anhui provincial cancer hospital Hefei, Anhui, China
  • The first affiliated hospital of Anhui medical university Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 43 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

NCT06425302

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 0152 Birmingham, Alabama, United States
  • Local Institution - 0055 Anchorage, Alaska, United States
  • Local Institution - 0180 Phoenix, Arizona, United States
  • Local Institution - 0190 Tucson, Arizona, United States
View all 56 locations
View Trial Details
Active, Not Recruiting

Copanlisib Plus Venetoclax in R/R DLBCL

NCT04572763

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Siteman Cancer Center at Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

NCT04882475

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy
  • AOU Senese - U.O.C. Ematologia Siena, SI, Italy
  • Centro Riferimento Oncologico - S.O.C. Oncologia Medica A Aviano, Italy
  • ASST Spedali Civili di Brescia - Ematologia Brescia, Italy
View all 16 locations
View Trial Details

Related conditions